Skip to main content

State of Human H5N1 Therapeutics: A Rapid Expert Consultation

Completed

The National Academies of Sciences, Engineering, and Medicine is undertaking a rapid expert consultation to assess current and emerging therapeutic options for Highly Pathogenic Avian Influenza A (H5N1) in humans. The consultation will examine the effectiveness and availability of existing treatments, identify promising therapeutics in development, and explore how these options could be most effectively deployed in the event of sustained human-to-human H5N1 transmission or a potential influenza pandemic. Experts will also discuss research needs, regulatory considerations, and allocation strategies to ensure equitable and effective use of limited supplies.

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.